Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/197671
Title: Sex Differences in Motor and Non-Motor Symptoms among Spanish Patients with Parkinson’s Disease
Author: Santos García, Diego
Laguna, Ariadna
Hernández Vara, Jorge
Deus Fonticoba, Teresa de
Cores Bartolomé, Carlos
Feal Painceiras, Maria J.
Íñiguez Alvarado, Maria Cristina
García Díaz, Iago
Jesús, Silvia
Boungiorno, Maria Teresa
Planellas, Lluís
Cosgaya, Marina
García Caldentey, Juan
Caballol, Núria
Legarda, Ines
Cabo, Iria
López Manzanares, Lydia
González Aramburu, Isabel
Ávila Rivera, Maria A.
Gómez Mayordomo, Víctor
Nogueira, Víctor
Puente, Víctor
Dotor García-Soto, Julio
Borrué, Carmen
Solano Vila, Berta
Álvarez Sauco, María
Vela, Lydia
Escalante, Sonia
Cubo, Esther
Carrillo Padilla, Francisco
Castrillo, Juan C. Martínez
Sánchez Alonso, Pilar
Alonso Losada, Maria G.
López Ariztegui, Nuria
Gastón, Itziar
Kulisevsky, Jaime
Menéndez González, Manuel
Seijo, Manuel
Rúiz Martínez, Javier
Valero, Caridad
Kurtis, Mónica
González Ardura, Jessica
Alonso Redondo, Ruben
Ordás, Carlos
López Díaz, Luis M.
Mcafee, Darrian
Martinez Martin, Pablo
Mir, Pablo
COPPADIS Study Group
Keywords: Malaltia de Parkinson
Factors sexuals en les malalties
Parkinson's disease
Sex factors in disease
Issue Date: 7-Feb-2023
Publisher: MDPI AG
Abstract: Background and objective: Sex plays a role in Parkinson's disease (PD) mechanisms. We analyzed sex difference manifestations among Spanish patients with PD. Patients and Methods: PD patients who were recruited from the Spanish cohort COPPADIS from January 2016 to November 2017 were included. A cross-sectional and a two-year follow-up analysis were conducted. Univariate analyses and general linear model repeated measure were used. Results: At baseline, data from 681 PD patients (mean age 62.54 +/- 8.93) fit the criteria for analysis. Of them, 410 (60.2%) were males and 271 (39.8%) females. There were no differences between the groups in mean age (62.36 +/- 8.73 vs. 62.8 +/- 9.24; p = 0.297) or in the time from symptoms onset (5.66 +/- 4.65 vs. 5.21 +/- 4.11; p = 0.259). Symptoms such as depression (p < 0.0001), fatigue (p < 0.0001), and pain (p < 0.00001) were more frequent and/or severe in females, whereas other symptoms such as hypomimia (p < 0.0001), speech problems (p < 0.0001), rigidity (p < 0.0001), and hypersexuality (p < 0.0001) were more noted in males. Women received a lower levodopa equivalent daily dose (p = 0.002). Perception of quality of life was generally worse in females (PDQ-39, p = 0.002; EUROHIS-QOL8, p = 0.009). After the two-year follow-up, the NMS burden (Non-Motor Symptoms Scale total score) increased more significantly in males (p = 0.012) but the functional capacity (Schwab and England Activities of Daily Living Scale) was more impaired in females (p = 0.001). Conclusion: The present study demonstrates that there are important sex differences in PD. Long-term prospective comparative studies are needed.
Note: Reproducció del document publicat a: https://doi.org/10.3390/jcm12041329
It is part of: Journal of Clinical Medicine, 2023, vol. 12, num. 4
URI: http://hdl.handle.net/2445/197671
Related resource: https://doi.org/10.3390/jcm12041329
ISSN: 2077-0383
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
jcm-12-01329-v2.pdf921.91 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons